Inventor · disambiguated record
Michael D. Varney
Also filed as: VARNEY MICHAEL D · VARNEY MICHAEL DAVID
32 granted patents·4 pending applications·972 citations·filing 1993–2006
97Inventor score
Files withAGOURON PHARMA30CANAN KOCH STACIE S2AGOURON PHARAMACEUTICALS INC1AGOURON PHARMACETICALS INC1
Top patents by PatentIndex Score
36 records- 0198US6884890B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted Apr 26, 2005·178 cites·32 claims
- 0298US6534524B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2001·Granted Mar 18, 2003·277 cites·14 claims
- 0396US6531491B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARAMACEUTICALS INC·Filed 2001·Granted Mar 11, 2003·200 cites·10 claims
- 0493US6635641B2Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2001·Granted Oct 21, 2003·83 cites·11 claims
- 0591US6891044B2Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 10, 2005·20 cites·43 claims
- 0690US7141587B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2004·Granted Nov 28, 2006·17 cites·9 claims
- 0787US5608082ACompounds useful as antiproliferative agents and GARFT inhibitorsAGOURON PHARMA·Filed 1994·Granted Mar 4, 1997·27 cites·11 claims
- 0881US5707992AAntiproliferative quinazolinesAGOURON PHARMA·Filed 1995·Granted Jan 13, 1998·44 cites·60 claims
- 0976US5885996AAntiproliferative quinazolinesAGOURON PHARMA·Filed 1997·Granted Mar 23, 1999·36 cites·6 claims
- 1075US5646141ACompounds useful as antiproliferative agents and GARFT inhibitorsAGOURON PHARMA·Filed 1995·Granted Jul 8, 1997·17 cites·31 claims
- 1170US6953858B2HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesisAGOURON PHARMA·Filed 2002·Granted Oct 11, 2005·4 cites·16 claims
- 1267US6525050B1(4-oxo-2-pyrimidinyl)thioalkyl compounds useful as AICARFT inhibitorsAGOURON PHARMA·Filed 1999·Granted Feb 25, 2003·11 cites·4 claims
- 1366US5641774ACompounds useful as antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Jun 24, 1997·6 cites·29 claims
- 1465US6207670B1Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsAGOURON PHARMA·Filed 2000·Granted Mar 27, 2001·1 cites·9 claims
- 1560US5739141AAntiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsAGOURON PHARMA·Filed 1993·Granted Apr 14, 1998·9 cites·33 claims
- 1658US5594139AProcesses for preparing antiproliferative garft-inhibiting compoundsAGOURON PHARMA·Filed 1994·Granted Jan 14, 1997·7 cites·12 claims
- 1755US2007021354A1HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesisCANAN KOCH STACIE S·Filed 2006·Application pending·0 cites
- 1854US5726312AMethods for preparing antiproliferative 5-substituted pyrimidone compoundsAGOURON PHARMA·Filed 1995·Granted Mar 10, 1998·7 cites·9 claims
- 1953US6323210B2Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsAGOURON PHARMA·Filed 2001·Granted Nov 27, 2001·0 cites·4 claims
- 2053US2002173515A1Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsFiled 2001·Application pending·0 cites
- 2152US2005250707A1HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesisCANAN KOCH STACIE S·Filed 2005·Application pending·0 cites
- 2250US7179918B2HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesisAGOURON PHARMA·Filed 2002·Granted Feb 20, 2007·0 cites·24 claims
- 2349US6001851AHIV protease inhibitorsAGOURON PHARMA·Filed 1998·Granted Dec 14, 1999·4 cites·34 claims
- 2447US5945427AAntiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsAGOURON PHARMA·Filed 1998·Granted Aug 31, 1999·3 cites·33 claims
- 2547US5723607ACompounds useful as antiproliferative agents and GARFT inhibitorsAGOURON PHARMACETICALS INC·Filed 1997·Granted Mar 3, 1998·2 cites·3 claims
- 2647US2004092747A1Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useFiled 2003·Application pending·0 cites
- 2746US5981748ASynthesis of optically pure compounds useful as GARFT inhibitors and their intermediatesAGOURON PHARMA·Filed 1998·Granted Nov 9, 1999·2 cites·13 claims
- 2846US5639749ACompounds useful as antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Jun 17, 1997·3 cites·10 claims
- 2946US5625061ACompounds useful in preparing antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Apr 29, 1997·3 cites·8 claims
- 3046US5498727APreparation of benzindole compounds from naphthalene compoundsAGOURON PHARMA·Filed 1994·Granted Mar 12, 1996·3 cites·17 claims
- 3145US5639747ACompounds useful as antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Jun 17, 1997·1 cites·48 claims
- 3240US5831100ASyntheses of optically pure compounds useful as GARFT inhibitors and their intermediatesAGOURON PHARMA·Filed 1995·Granted Nov 3, 1998·1 cites·1 claims
- 3339US5641771ACompounds useful as antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Jun 24, 1997·1 cites·10 claims
- 3439US5610319ACompound useful as antiproliferative agents and GARFT inhibitorsAGOURON PHARMA·Filed 1995·Granted Mar 11, 1997·1 cites·12 claims
- 3537US5574039AAntiproliferative compounds having nitrogen-containing tricyclic ring systems and phenyl substituentsAGOURON PHARMA·Filed 1994·Granted Nov 12, 1996·3 cites·20 claims
- 3632US5545744ACyano naphthalene compoundsAGOURON PHARMA·Filed 1995·Granted Aug 13, 1996·1 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →